NZ703345A - Compositions and methods for reducing frequency and/or severity of headache - Google Patents

Compositions and methods for reducing frequency and/or severity of headache

Info

Publication number
NZ703345A
NZ703345A NZ703345A NZ70334513A NZ703345A NZ 703345 A NZ703345 A NZ 703345A NZ 703345 A NZ703345 A NZ 703345A NZ 70334513 A NZ70334513 A NZ 70334513A NZ 703345 A NZ703345 A NZ 703345A
Authority
NZ
New Zealand
Prior art keywords
headache
severity
subject
frequency
reducing
Prior art date
Application number
NZ703345A
Other languages
English (en)
Inventor
Ralph Bright
Pelin Bright
Bruce Hansen
Wayne Thomas
Original Assignee
Rusty Property Holdings Pty Ltd
Amberdale Entpr Pty Ltd
Tavid Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012902720A external-priority patent/AU2012902720A0/en
Application filed by Rusty Property Holdings Pty Ltd, Amberdale Entpr Pty Ltd, Tavid Pty Ltd filed Critical Rusty Property Holdings Pty Ltd
Publication of NZ703345A publication Critical patent/NZ703345A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Vascular Medicine (AREA)
NZ703345A 2012-06-26 2013-06-26 Compositions and methods for reducing frequency and/or severity of headache NZ703345A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2012902720A AU2012902720A0 (en) 2012-06-26 Compositions and methods for reducing frequency and/or severity of headache
PCT/AU2013/000684 WO2014000029A1 (en) 2012-06-26 2013-06-26 Compositions and methods for reducing frequency and/or severity of headache

Publications (1)

Publication Number Publication Date
NZ703345A true NZ703345A (en) 2017-03-31

Family

ID=49781943

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ703345A NZ703345A (en) 2012-06-26 2013-06-26 Compositions and methods for reducing frequency and/or severity of headache

Country Status (9)

Country Link
US (1) US10206956B2 (enExample)
EP (1) EP2863927A4 (enExample)
JP (1) JP2015521630A (enExample)
KR (1) KR20150091037A (enExample)
CN (1) CN104902909A (enExample)
AU (1) AU2013284338B2 (enExample)
CA (1) CA2877022A1 (enExample)
NZ (1) NZ703345A (enExample)
WO (1) WO2014000029A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014262376A1 (en) * 2013-05-10 2015-11-26 Cell-Innovations Ip Pty Ltd Compositions and methods for the treatment of tinnitus
CN105555326B (zh) * 2013-07-01 2019-05-14 A·P·高伟尔 软组织植入物
US10456419B2 (en) 2017-02-27 2019-10-29 Payman Sadeghi Method for treating migraine headaches
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection
JP6829225B2 (ja) * 2018-06-13 2021-02-10 株式会社 バイオミメティクスシンパシーズ モノアミン産生増加剤としての間葉系幹細胞を含む医薬組成物
CN110772535A (zh) * 2018-07-12 2020-02-11 南通大学 多系分化持续应激细胞在制备镇痛药物中的应用
JP6497827B1 (ja) * 2018-07-17 2019-04-10 株式会社 バイオミメティクスシンパシーズ エイコサノイド産生促進剤
US20210395693A1 (en) 2018-10-26 2021-12-23 Guy MARTI Method and apparatus for mesenchymal stem cells isolation and purification
JP2023549530A (ja) * 2020-11-13 2023-11-27 アドバンスト・セラピューティック・ラブ・インコーポレイテッド 脂肪組織に由来する間質血管細胞群を利用した治療方法及び組成物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2366078C (en) 1999-03-10 2015-09-01 University Of Pittsburgh Of The Commonwealth System Of Higher Education Adipose-derived stem cells and lattices
MXPA04004311A (es) * 2001-11-09 2005-03-31 Artecel Sciences Inc DIFERENCIACION DEL PáNCREAS ENDOCRINOS DE CELULAS ESTROMALES DERIVADAS DEL TEJIDO ADIPOSO Y USOS DE LAS MISMAS.
AU2004263009B2 (en) 2003-08-07 2009-12-24 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
AU2004280616A1 (en) * 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
FR2901136B1 (fr) * 2006-05-18 2010-10-01 Centre Nat Rech Scient Utilisation de cellules derivees du tissu adipeux pour la preparation d'un medicament anti-tumoral
JP2010037292A (ja) 2008-08-06 2010-02-18 Univ Of Tokyo 脂肪由来幹細胞と塩基性線維芽細胞増殖因子を組み合わせた線維性病変の治療法
KR20110050521A (ko) 2008-08-20 2011-05-13 안트로제네시스 코포레이션 개선된 세포 조성물 및 그의 제조 방법
US8828376B2 (en) * 2008-08-20 2014-09-09 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
PT2379087E (pt) * 2008-12-19 2014-12-02 Depuy Synthes Products Llc Células derivadas do tecido do cordão umbilical para o tratamento da dor neuropática e espasticidade
AU2009100401A4 (en) * 2009-04-30 2009-06-04 Gl Holdings Inc Bv Method of extracting and activating adipose-derived stem cells
JP5917392B2 (ja) 2009-05-01 2016-05-11 ビミニ テクノロジーズ リミテッド ライアビリティ カンパニー 組織及び細胞富化グラフトを最適化するシステム、方法及び組成物
JP2011010581A (ja) 2009-06-30 2011-01-20 Kaneka Corp 幹細胞分離材、幹細胞分離フィルター、及び該分離材または該分離フィルターを用いた幹細胞分離方法、幹細胞回収方法
JP5905446B2 (ja) 2010-03-24 2016-04-20 ライフネット ヘルス Ｂｍｐ−４ペプチドおよび使用方法
JP2013528368A (ja) 2010-05-06 2013-07-11 ステム セル メディスン リミテッド 個の医療のための幹細胞バンク
WO2012083024A1 (en) * 2010-12-17 2012-06-21 Anthrogenesis Corporation Treatment of spinal cord injury and traumatic brain injury using placental stem cells
CN103443272A (zh) * 2010-12-27 2013-12-11 智能细胞生物科学有限公司 从脂肪组织获得的源自超声空化的基质或间充质血管提取物和源自其的细胞以及其用途
KR101835917B1 (ko) * 2011-03-22 2018-03-07 플루리스템 리미티드 방사선 또는 화학적 손상을 치료하는 방법들
PT2714059T (pt) * 2011-06-01 2019-02-04 Celularity Inc Tratamento da dor utilizando células estaminais da placenta
JP5598864B2 (ja) * 2011-12-05 2014-10-01 北海道公立大学法人 札幌医科大学 細胞増殖方法ならびに組織の修復および再生のための医薬

Also Published As

Publication number Publication date
JP2015521630A (ja) 2015-07-30
CN104902909A (zh) 2015-09-09
US10206956B2 (en) 2019-02-19
AU2013284338B2 (en) 2018-03-01
EP2863927A4 (en) 2015-12-02
WO2014000029A1 (en) 2014-01-03
US20150174172A1 (en) 2015-06-25
AU2013284338A1 (en) 2015-01-22
KR20150091037A (ko) 2015-08-07
EP2863927A1 (en) 2015-04-29
CA2877022A1 (en) 2014-01-03

Similar Documents

Publication Publication Date Title
NZ703345A (en) Compositions and methods for reducing frequency and/or severity of headache
WO2013070881A8 (en) Method for elimination of space through tissue approximation
MX390739B (es) Composicion de hueso comprimido y metodo para usar la misma.
MY178152A (en) Isolation of stem cells from adipose tissue by ultrasonic cavitation, and methods of use
MX381456B (es) Regulador de ph de transduccion.
IL229284A0 (en) Assemblies of matrix material, non-cellular, extracellular, sterile, and methods for their production
WO2014058804A3 (en) Micronized compositions composed of bone grafts and methods of making and using the same
UA116088C2 (uk) Спосіб та композиція для боротьби з бур'янами (варіанти)
SG10201901713RA (en) Extracellular matrix compositions
IN2015DN03322A (enExample)
MX2015015116A (es) Composicion de sustituto de crema de comprende microparticulas de proteinas vegetales.
HK1218139A1 (zh) 去分化的重新編程細胞所衍生的細胞組合物
BR112016030758B8 (pt) Uso de células estromais multipotentes derivadas de tecido adiposo mesenquimal
IL274538B (en) A preparation containing mesenchymal stem cells for tissue regeneration and a method for its production
PH12015502405A1 (en) Methods and compositions for wound healing
PT2932989T (pt) Selante de tecido no qual estão misturados colagénio e fibrina, e método para o preparar
MX2016016756A (es) Terapia con células madre en patologías endometriales.
CA2980120C (en) COMPOSITION AND DISINTEGRATION PROCESS OF TISSUE MATERIAL
MX362175B (es) Composiciones de proteina del gen 3 de bacteriofago y sus usos como agentes de union amiloides.
HK1202375A1 (en) Skin lightening compositions
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
MX2015006986A (es) Solucion de trombina y metodos de uso de esta.
PH12012501548A1 (en) Compositions comprising sugar-cysteine products
EP2902413A4 (en) POLYPEPTIDE, FRUIT COMPOSITION, COMPOSITION FOR CARTILAGE RANGE TESTING, COMPOSITION FOR CORTIC CELL CULTURE AND COMPOSITION FOR PROMOTING GLYCOSAMINOGLYCAN PRODUCTION
WO2012119103A3 (en) Compositions and methods for mobilization of stem cells